{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:07:46Z","timestamp":1793642866131,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11845-025-03969-6","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:46:00Z","timestamp":1748839560000},"page":"1329-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The effect of IL-17 and IL-23 \u0131nhibitors on hematological \u0131nflammatory parameters in patients with psoriasis vulgaris"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-0619","authenticated-orcid":false,"given":"Mehmet Semih","family":"\u00c7elik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-500X","authenticated-orcid":false,"given":"Hamza","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"3969_CR1","doi-asserted-by":"crossref","unstructured":"Guo J, Zhang H, Lin W et al (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 27 Kas\u0131m 8:437","DOI":"10.1038\/s41392-023-01655-6"},{"issue":"4","key":"3969_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ (2020) Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol Nisan 182(4):840\u2013848","journal-title":"Br J Dermatol Nisan"},{"key":"3969_CR3","doi-asserted-by":"crossref","unstructured":"Elmets CA, Leonardi CL, Davis DMR et al (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. Nisan 80(4):1073\u2013113","DOI":"10.1016\/j.jaad.2018.11.058"},{"key":"3969_CR4","doi-asserted-by":"crossref","unstructured":"Gargiulo L, Ibba L, Malagoli P et al (2024) Drug survival of IL-12\/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses \u2013 IL PSO (Italian landscape psoriasis). Front Immunol. 11 Ocak 14:1341708","DOI":"10.3389\/fimmu.2023.1341708"},{"key":"3969_CR5","doi-asserted-by":"crossref","unstructured":"Wang WM, Wu C, Gao YM et al (2021) Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients. BMC Immunol. 26 Eyl\u00fcl 22:64","DOI":"10.1186\/s12865-021-00454-4"},{"key":"3969_CR6","doi-asserted-by":"crossref","unstructured":"Ye JH, Zhang Y, Naidoo K, Ye S (2024) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis. Arch Dermatol Res. 08 \u015eubat 316(3):85","DOI":"10.1007\/s00403-024-02823-6"},{"key":"3969_CR7","doi-asserted-by":"publisher","first-page":"1395993","DOI":"10.3389\/fimmu.2024.1395993","volume":"15","author":"A Zinellu","year":"2024","unstructured":"Zinellu A, Mangoni AA (2024) The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis. Front Immunol 15:1395993","journal-title":"Front Immunol"},{"issue":"3","key":"3969_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4274\/cayd.galenos.2021.25483","volume":"9","author":"S\u0130 \u00d6zdemir","year":"2022","unstructured":"\u00d6zdemir S\u0130, Ak\u00e7a H, Kurt AN\u00c7 (2022) Neutrophil-lymphocyte and platelet-lymphocyte ratios in febrile seizures. J Pediatr Emerg Intensive Care Med 9(3):158\u2013161","journal-title":"J Pediatr Emerg Intensive Care Med"},{"key":"3969_CR9","doi-asserted-by":"crossref","unstructured":"Qin B, Ma N, Tang Q et al (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26(3):372\u20136","DOI":"10.3109\/14397595.2015.1091136"},{"key":"3969_CR10","doi-asserted-by":"crossref","unstructured":"C\u00e1ceda-Samam\u00e9 RF, Vela-Salazar MR, Alejandro-Salinas R et al (2024) Prognostic performance of neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio for mortality in patients with acute stroke. Hipertens Riesgo Vasc. 01 Ocak 41(1):26\u201334.","DOI":"10.1016\/j.hipert.2023.10.002"},{"key":"3969_CR11","doi-asserted-by":"crossref","unstructured":"Ye M, Qian X, Guo X et al (2020) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict severity and prognosis of lower limb arteriosclerosis obliterans. Ann Vasc Surg. 01 Nisan 64:221\u20137","DOI":"10.1016\/j.avsg.2019.09.005"},{"issue":"6","key":"3969_CR12","first-page":"606","volume":"105","author":"E Durmus","year":"2015","unstructured":"Durmus E, Kivrak T, Gerin F et al (2015) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure. Arq Bras Cardiol Aral\u0131k 105(6):606\u2013613","journal-title":"Arq Bras Cardiol Aral\u0131k"},{"issue":"4","key":"3969_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4103\/ijd.ijd_935_21","volume":"67","author":"S Mondal","year":"2022","unstructured":"Mondal S, Guha S, Saha A et al (2022) Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic plaque psoriasis. Indian J Dermatol A\u011fustos 67(4):477","journal-title":"Indian J Dermatol A\u011fustos"},{"issue":"12","key":"3969_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077596","volume":"13","author":"J Hong","year":"2023","unstructured":"Hong J, Lian N, Li M (2023) Association between the neutrophil-to-lymphocyte ratio and psoriasis: a cross-sectional study of the National Health and Nutrition Examination Survey 2011\u20132014. BMJ Open 13(12):e077596","journal-title":"BMJ Open"},{"key":"3969_CR15","doi-asserted-by":"crossref","unstructured":"Kommoss KS, Bieler T, Ringen J et al (2024) A simple tool for evaluation of inflammation in psoriasis: neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease. J Mol Med. 01 \u015eubat 102(2):247\u201355","DOI":"10.1007\/s00109-023-02406-4"},{"issue":"2","key":"3969_CR16","first-page":"291","volume":"5","author":"M Melikoglu","year":"2023","unstructured":"Melikoglu M, Pala E (2023) Systemic immune-inflammation index as a biomarker of psoriasis severity. Arch Basic Clin Res 5(2):291\u2013295","journal-title":"Arch Basic Clin Res"},{"key":"3969_CR17","doi-asserted-by":"crossref","unstructured":"Basar Kilic S, Erdal H (2025) Pan-immune inflammation value and systemic inflammatory index as a measure of systemic inflammation in patients with psoriasis: a retrospective study. Medicine (Baltimore). 07 Mart 104(10):e41715","DOI":"10.1097\/MD.0000000000041715"},{"key":"3969_CR18","doi-asserted-by":"crossref","unstructured":"Morariu SH, Cotoi OS, Tiuc\u0103 OM et al (2024) Blood-count-derived inflammatory markers as predictors of response to biologics and small-molecule inhibitors in psoriasis: a multicenter study. J Clin Med. Ocak 13(14):3992","DOI":"10.3390\/jcm13143992"},{"key":"3969_CR19","doi-asserted-by":"crossref","unstructured":"Demirel \u00d6\u011f\u00fct N, Ayano\u011flu MA, Ko\u00e7 Y\u0131ld\u0131r\u0131m S et al (2025) Are IL-17 inhibitors superior to IL-23 inhibitors in reducing systemic inflammation in moderate-to-severe plaque psoriasis? A retrospective cohort study. Arch Dermatol Res. 13 Ocak 317(1):232","DOI":"10.1007\/s00403-024-03768-6"},{"key":"3969_CR20","doi-asserted-by":"crossref","unstructured":"Unal M (2016) Platelet mass index is increased in psoriasis. A possible link between psoriasis and atherosclerosis. Arch Med Sci Atheroscler Dis. 06 Aral\u0131k 1(1):e145\u20139","DOI":"10.5114\/amsad.2016.64444"},{"key":"3969_CR21","doi-asserted-by":"crossref","unstructured":"Chen TL, Lee LL, Huang HK et al (2022) Association of psoriasis with incident venous thromboembolism and peripheral vascular disease: a systematic review and meta-analysis. JAMA Dermatol. 01 Ocak 158(1):59\u201367","DOI":"10.1001\/jamadermatol.2021.4918"},{"key":"3969_CR22","doi-asserted-by":"crossref","unstructured":"Liu Z, Perry LA, Morgan V (2023) The association between platelet indices and presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med. 01 Haziran 23(2):333\u201346","DOI":"10.1007\/s10238-022-00820-5"},{"key":"3969_CR23","doi-asserted-by":"crossref","unstructured":"Lee SH, Kim M, Han KD, Lee JH (2021) Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease. Sci Rep. 20 Temmuz 11:14741","DOI":"10.1038\/s41598-021-94165-w"},{"issue":"8","key":"3969_CR24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/exd.14771","volume":"32","author":"S Patel","year":"2023","unstructured":"Patel S, Yang K, Malik R et al (2023) Impact of deficiency anaemia comorbidity in generalized pustular psoriasis hospitalizations. Exp Dermatol 32(8):1314\u20131316","journal-title":"Exp Dermatol"},{"key":"3969_CR25","doi-asserted-by":"crossref","unstructured":"Ozbeyaz NB, Gokhan G, Gezer AE et al (2022) Novel marker for predicting the severity and prognosis of acute pulmonary embolism: platelet-to-hemoglobin ratio. Biomark Med 16(12):915\u201324","DOI":"10.2217\/bmm-2022-0201"},{"key":"3969_CR26","doi-asserted-by":"crossref","unstructured":"I\u015f\u0131k F, Soner S (2022) Platelet-to-hemoglobin ratio is an important predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction. Cureus 14(7):e26833","DOI":"10.7759\/cureus.26833"},{"key":"3969_CR27","doi-asserted-by":"crossref","unstructured":"Bao K, Huang H, Huang G et al (2021) Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure. BMC Cardiovasc Disord. 28 Aral\u0131k 21:618","DOI":"10.1186\/s12872-021-02423-6"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03969-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-03969-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-03969-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T23:19:50Z","timestamp":1757459990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-03969-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3969"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-03969-6","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Gazi Ya\u015fargil Education and Research Hospital (262\/2024). This study was conducted in accordance with the principles of the Helsinki Declaration. Informed consent was obtained from the participants to participate in the study.cal","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no conflict of interest related to the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}